Report Description Table of Contents Industry Report and Statistics (Facts & Figures) - Sales Volume, Procedure Conducted & ASP by Product, Application & End-User The global angioplasty balloons market will witness a robust CAGR of 4.10%, valued at $2.60 billion in 2021, expected to appreciate and reach $3.73 billion by 2030, confirms Strategic Market Research. North America significantly held the maximum share of the market in 2020, and it is expected to continue its sheer dominance throughout the forecasted period. Angioplasty, also termed balloon angioplasty & percutaneous transluminal angioplasty, is considered a MI (minimally invasive) endovascular procedure. It is used to widen narrowed or obstructed arteries or veins to treat arterial atherosclerosis. A balloon-tipped catheter is implemented in angioplasty to clear a blocked blood vessel and improve blood flow throughout the human body. The angioplasty technique is primarily performed in a cardiac attack. The Global Health and Wellness Report of 2018 confirmed that approximately 40% of the adult population in the United States had been diagnosed with cardiovascular disease. Also, according to the Foundation de France, one out of every three adults in France is at risk of developing cardiovascular disease. In France, around 130,000 heart attacks and 120,000 strokes occur each year, which in turn is increasing the demand for Angioplasty balloons globally, thereby driving its industry growth. Market Drivers - An Increasing Number of Cardiovascular Diseases, the Impact of Covid 19, Rising Geriatric Population According to the World Health Organization (WHO), the United States has roughly 8 million people with peripheral artery disease. Coronary heart disease is the major cause of mortality in the country, accounting for over half of fatalities. Over the predicted period, the prevalence of these disorders is expected to rise. Furthermore, a rising elderly population with heart disease and diabetes is predicted to drive up the demand for angioplasty balloon catheters throughout the forecasted period. Also, as per a survey performed by the Health Protection Agency, around 610,000 individuals die in the U.S. every year due to cardiac abnormalities, with the number continuing to rise in due course of time. According to the World Aging Population Report, the worldwide population of netizens aged 65 or more was estimated to be about 702.9 million in 2019, which is projected to rise up to 1548.9 million by 2050. As the senior population grows, chronic illnesses are predicted to rise, leading to more hospitalizations and surgeries. Furthermore, the increasing cases of Atherosclerosis and Carotid artery injury are increasing the demand for Percutaneous Transluminal Coronary Angioplasty, Coronary artery stents, Brachytherapy, Carotid artery angioplasty, Cerebral angioplasty, heart balloon angioplasty, and Cardiac Catheterization, hence driving the overall angioplasty balloons market growth. Restraints - Low Awareness in Underdeveloped Countries In developing nations, a lack of knowledge will hinder market expansion. In addition, the industry will likely face challenges due to the scarcity of experienced medical personnel, high surgical procedure costs, and a lack of favorable reimbursement policies in emerging and undeveloped nations. Furthermore, increased product recalls and clinical risks or consequences of surgical procedures may stifle the industry's growth. Opportunities - Increasing Prevalence of Target Illnesses One of the major reasons driving the market expansion is an increase in the prevalence of target diseases. According to the WHO (World Health Organization), cardiovascular diseases impact 485.6 million people worldwide, with 17.9 million deaths. This figure represents 35% of all fatalities worldwide. Furthermore, heart attacks account for 85 percent of all fatalities associated with cardiovascular disease. Also, increasing awareness of the minimally invasive surgical procedures, Balloon angioplasty success rate, the launch of innovative products, and the rising prevalence of coronary and peripheral artery diseases in developing countries are expected to cater to ample opportunities for industry growth in the future. Furthermore, the rise in usage of drug-eluting stents and the untapped potential of emerging markets contribute to lucrative market growth opportunities. Market Analysis Of Different Segments Covered in the Report Based on the Product Type Normal Balloons Scoring Balloons Drug-eluting balloons Cutting balloon Based on Application Coronary Peripheral Based on End-user Ambulatory Surgery Centres (ASCs) Hospitals Catheterization Laboratories Regional Coverage Analysis North America The U.S. Canada Mexico Rest of North America Europe France Germany U.K Spain Italy Rest of Europe Asia Pacific China India Japan Australia Rest of APAC LAMEA Brazil Saudi Arabia South Africa Rest of LAMEA Product Type Analysis & Insights The Normal Balloons segment held the largest industry share in 2020 due to the lower cost of these devices, supportive government laws and approval processes, and attractive reimbursement policies. However, the fastest-growing segment is expected to be the Drug-Eluting Balloons (DEBs). Favorable reimbursement procedures resulted in an increase in DEB sales, which is expected to continue in the foreseeable years. The launch of new devices, the benefits of DEBs over ordinary balloons, and the cheaper cost of DEBs compared to stents contribute to the increasing growth of this segment. Application Analysis & Insights Based on the Application, the Coronary segment held the largest angioplasty balloons market share in 2020 because of the high prevalence of coronary artery disease, one of the prominent types of heart disease. According to the CDC, these diseases cause approximately 370,000 deaths per year globally. Also, the World Health Organization asserted that Heart disease had remained the leading cause of death worldwide for the last 20 years. The number of fatalities from heart diseases increased from 2 Mn in 2000 to approximately 9 million in 2019. On the other hand, because of the increasing number of approvals for innovative drugs and devices, Peripheral artery diseases are expected to be the fastest-growing segment in the upcoming years. Furthermore, increased awareness of disorders affecting the peripheral arteries and the availability of improved products are predicted to propel the market forward. The CDC has announced that approximately 6.5 million people aged 40 years or older in the United States suffer from PAD. End-User Analysis & Insights Based on the End-user, the Hospital segment is expected to have the largest industry share in 2020. Advanced healthcare infrastructure, rising availability of skilled healthcare professionals, and affordability drive this segment's supremacy. According to a report published by the Advanced Medical Technology Association (AdvaMed), India's move to cap the maximum prices of various cardiovascular surgical instruments has reduced angioplasty procedure costs in tier 1 by up to 18 percent. Region Analysis & Insights North America held the maximum share. The region's major drivers include the prevalence of significant players, a shift in FDA policy in the United States, and an increase in the frequency of percutaneous coronary procedures. The American College of Cardiology confirmed that around 1.2 million angioplasties are done yearly in the United States. Due to the rising healthcare spending and excellent government support, the Asia Pacific is likely to be the most attractive and fastest-growing geographical market throughout the estimated period. Angioplasty Balloons Market Report Coverage Report Attribute Details Forecast Period 2021 - 2030 The market size value in 2021 USD 2.60 billion The revenue forecast in 2030 USD 3.73 billion Growth rate CAGR of approximately 4.10% The base year for estimation 2021 Unit USD Billion, CAGR (2021 - 2030) Segmentation By Product, By Application, By End-user, By Region By Product Normal Balloons, Scoring Balloons, Drug-eluting balloons, Cutting balloon By Application Coronary, Peripheral By End-user Ambulatory Surgery Centres (ASCs), Hospitals, Catheterization Laboratories By Region Asia Pacific, North America, Europe, LAMEA Country Scope U.S., Canada, France, Germany, U.K., China, Japan, India, South Korea, Mexico, Brazil, U.A.E. etc. Company Usability Profiles Spectranetics Corp., Becton, Medtronic PLC, Boston Scientific Corporation; Cook Medical, Inc., Dickinson and Company (C. R. Bard, Inc.), Cardinal Health (Cordis), ENDOCOR GmbH, Johnson & Johnson, Abbott Laboratories, etc. Angioplasty Balloons Market Competitive Landscape Analysis The competitive landscape analysis provides information about the crucial competitors prevailing in the global environment. The comparison is performed based on overall revenue generation, market initiatives, company overview, investment in R&D, company financials, company strengths and weaknesses, global presence, production capacity, production sites and facilities, market potential, etc. Boston Scientific Corporation Medtronic PLC Spectranetics Corp. Becton, Dickinson and Company Abbott Laboratories Cook Medical, Inc. Cardinal Health ENDOCOR GmbH Johnson & Johnson SINOMED Biotronik Recent Developments In August 2021, by collaborating with the National University of Ireland Galway (NUI Galway), SINOMED, a prominent global medical device company, announced the first commercial implantation of the HT Supreme Drug-Eluting Stent (DES) at University Hospital Galway, thereby promoting and advancing the European launch. In January 2021, The JADE 0.014", 0.018", and 0.035" OTW non-compliant peripheral balloon dilatation catheter series from OrbusNeich Medical Co. Ltd received authorization from the US Food and Drug Administration (FDA). The JADE OTW Balloon Dilatation Catheter for Percutaneous Transluminal Angioplasty (PTA) is an over-the-wire balloon catheter for percutaneous transluminal angioplasty of obstructed native arteries and synthetic arteriovenous dialysis fistulae. In November 2020, InfinityAngioplasty Balloon Co. announced the completion of a First-in-Human clinical study for their novel angioplasty balloon platform, the Infinity Angioplasty Balloon Catheter. In June 2020, the FDA approved the device for PTA treatment of peripheral artery diseases in peripheral vessels such as the iliac, femoral, popliteal, and infra-popliteal arteries and the treatment of A.V. dialysis fistulae. Frequently Asked Question About This Report What is the angioplasty balloons market growth? The global angioplasty balloons market is expected to grow at a compound annual growth rate (CAGR) of 4.10% from 2021 to 2030 to reach USD 3.73 billion by 2030. What is balloon angioplasty? Balloon angioplasty is a procedure used to unblock blocked or constricted arteries. It entails placing a catheter with a balloon attached to an artery. The balloon is inflated where plaque deposits have blocked or restricted blood flow. What material is used for angioplasty balloons? In Gruentzigs time, the first angioplasty balloons were manufactured of flexible PVC (polyvinyl chloride). Cross-linked polyethylene was employed in the next generation of balloon technology. Polyethene terephthalate (PET) or nylon are the most common materials used in the twenty-first century. How balloon is inflated in angioplasty? Balloon angioplasty surgery is a procedure in which interventional cardiologists open constricted arteries. They employ a catheter, which is a long, thin tube with a tiny balloon at the tip. They inflate the balloon (using an angioplasty balloon inflation device), flattening or compressing the plaque against the arterial wall at the obstruction site. What are the key segments covered in the angioplasty balloons market? The key segments inculcated in the angioplasty balloons market are Product Type, Application, End-users, and Region. What is the CAGR for the angioplasty balloons market? The global angioplasty balloons market share was around USD 2.60 Billion 2021, and it is forecasted to grow at a CAGR of 4.10% from 2021 to 2030. As a result, the global angioplasty balloons market Forecast suggests reaching around USD 3.73 Billion by 2030. How big is the angioplasty balloons market? The global angioplasty balloons market size was around $2.60 Billion in 2021 and is predicted to reach $3.73 Billion in 2030. Sources https://www.ahajournals.org/doi/10.1161/CIR.0000000000000558 https://www.fondationdefrance.org/en/cardiovascular-disease https://www.cdc.gov/heartdisease/facts.htm https://www.un.org/en/development/desa/population/publications/pdf/ageing/WorldPopulationAgeing2019-Highlights.pdf 1. Introduction 1.1. Study Objective 1.2. Market Definition 1.3. Study Scope 1.3.1. Markets Covered 1.3.2. Geographic Scope 1.3.3. Years Considered 1.3.4. Stakeholders 2. Research Methodology 2.1. Data Procurement 2.2. Paid Database 2.2.1. Secondary Data 2.2.1.1. Key Secondary sources 2.2.2. Primary Data 2.2.2.1 Primary sources 2.2.2.2. Key industry insights 2.2.2.3. Primary interviews with experts 2.2.2.4. Key primary respondent list 2.3. Market Size Estimation 2.4. Bottom-Up and Top-Down Approaches 2.4.1. Bottom-Up Approach 2.4.1.1. Approach for arriving at market size by bottom-up analysis 2.4.2. Top-Down Approach 2.4.2.1. Approach for Capturing Market Size by Top-Down Analysis 2.5. Market Breakdown and Data Triangulation 2.6. Research Methodology 2.7. Risk Assessment 3. Executive Summary 3.1 Angioplasty Balloons Market: Post-Covid-19 3.1.1 Actual Scenario 3.1.2 Pessimistic Scenario 3.1.3 Optimistic Scenario 3.1.4 Market Summary 4. Industry Outlook 4.1 Market Snapshot 4.2 Regional Analysis 4.2.1 market, by region, 2021-2030 (USD Million) 4.3 By Product Analysis 4.3.1 market, By Product, 2021-2030 (USD Million) 4.4 By End-user Analysis 4.4.1 market, By End-user, 2021-2030 (USD Million) 4.5 Application Analysis 4.5.1 market, By Application, 2021-2030 (USD Million) 4.6 Value Chain Analysis 4.7 Market Variable Analysis 4.7.1 Market Drivers Analysis 4.7.2 Market Restraints Analysis 4.8 Environment Analysis Tool 4.8.1 PEST analysis 4.8.2 Porter’s analysis 4.9 Penetration & Growth Prospect Mapping 5. Market Dynamics 5.1. Introduction 5.2. Market Dynamics 5.2.1. Drivers 5.2.2. Restraints 5.2.3. Opportunities 5.2.4. Challenges 5.3. Impact of Covid-19 On Market 5.4. Value Chain Analysis 5.5. Ecosystem 5.6. Patent Analysis 5.7. Trade Analysis 5.8. Tariff Analysis 5.9. Case Study Analysis 5.10. Porter’s Five Forces Analysis 5.10.1 Threat of New Entrants 5.10.2 Threat of Substitutes 5.10.3 Bargaining Power of Buyers 5.10.4 Bargaining Power of Suppliers 5.10.5 Degree of Competition 5.11. Application Analysis 5.11.1. Trends in Application (2014-2020) 5.11.2. Trends in Application (2021-2028) 5.12. Pricing Analysis 5.12.1. Average Price Trend Analysis (By Region, By Country) 6. Competitive & Vendor Landscape 6.1. Company Market Share Analysis 6.2. Manufacturing Sites, Area Served, Product Product 6.3. Market Competitive Situation and Trends 6.4. Manufacturers Mergers & Acquisitions, Expansion Plans 7. Global Market: By Product Segment Analysis 7.1. Introduction 7.2. Sales Volume & Revenue Analysis (2021-2030) 7.3. Normal Balloons 7.3.1. Normal Balloons market, 2021-2030 (USD Million) 7.4. Scoring Balloons 7.4.1. Scoring Balloons market, 2021-2030 (USD Million) 7.5. Drug-eluting balloons 7.5.1. Drug-eluting balloons market, 2021-2030 (USD Million) 7.6. Cutting balloon 7.6.1. Cutting balloon market, 2021-2030 (USD Million) 8. Global Market: By Application Segment Analysis 8.1. Introduction 8.2. Sales Volume & Revenue Analysis (2021-2030) 8.3. Coronary 8.3.1. Coronary market, 2021-2030 (USD Million) 8.4. Peripheral 8.4.1. Peripheral market, 2021-2030 (USD Million) 9. Global Market: By End-User Segment Analysis 9.1. Introduction 9.2. Sales Volume & Revenue Analysis (2021-2030) 9.3. Ambulatory Surgery Centres (ASCs) 9.3.1. Ambulatory Surgery Centres (ASCs) market, 2021-2030 (USD Million) 9.4. Hospitals 9.4.1. Hospitals market, 2021-2030 (USD Million) 9.5. Catheterization Laboratories 9.5.1. Catheterization Laboratories market, 2021-2030 (USD Million) 10. Global Market: Regional Outlook 10.1 North America 10.1.1. North America market, by By Product, 2021-2030 (USD Million) 10.1.2. North America market, by By End-user, 2021-2030 (USD Million) 10.1.3. North America market, by Application, 2021-2030 (USD Million) 10.1.4. North America market, by Country, 2021-2030 (USD Million) 10.1.4.1. U.S. 10.1.4.1.1. U.S. market, by By Product, 2021-2030 (USD Million) 10.1.4.1.2. U.S. market, by By End-user, 2021-2030 (USD Million) 10.1.4.1.3. U.S. market, by Application, 2021-2030 (USD Million) 10.1.4.2. Canada 10.1.4.2.1. Canada market, by By Product, 2021-2030 (USD Million) 10.1.4.2.2. Canada market, by By End-user, 2021-2030 (USD Million) 10.1.4.2.3. Canada market, by Application, 2021-2030 (USD Million) 10.2. Europe 10.2.1. Europe market, by By Product, 2021-2030 (USD Million) 10.2.2. Europe market, by By End-user, 2021-2030 (USD Million) 10.2.3. Europe market, by Application, 2021-2030 (USD Million) 10.2.4. Europe market, by country, 2021-2030 (USD Million) 10.2.4.1 U.K. 10.2.4.1.1. U.K. market, by By Product, 2021-2030 (USD Million) 10.2.4.1.2. U.K. market, by By End-user, 2021-2030 (USD Million) 10.2.4.1.3. U.K. market, by Application, 2021-2030 (USD Million) 10.2.4.2. Germany 10.2.4.2.1. Germany market, by By Product, 2021-2030 (USD Million) 10.2.4.2.2. Germany market, by By End-user, 2021-2030 (USD Million) 10.2.4.2.3. Germany market, by Application, 2021-2030 (USD Million) 10.2.4.3. France 10.2.4.3.1. France market, by By Product, 2021-2030 (USD Million) 10.2.4.3.2. France market, by By End-user, 2021-2030 (USD Million) 10.2.4.3.3. France market, by Application, 2021-2030 (USD Million) 10.2.4.4. Rest of Europe 10.2.4.4.1. Rest of Europe market, by By Product, 2021-2030 (USD Million) 10.2.4.4.2. Rest of Europe market, by By End-user, 2021-2030 (USD Million) 10.2.4.4.3. Rest of Europe market, by Application, 2021-2030 (USD Million) 10.3. Asia Pacific 10.3.1. Asia Pacific market, by By Product, 2021-2030 (USD Million) 10.3.2. Asia Pacific market, by By End-user, 2021-2030 (USD Million) 10.3.3. Asia Pacific market, by Application, 2021-2030 (USD Million) 10.3.4. Asia Pacific market, by country, 2021-2030 (USD Million) 10.3.4.1. China 10.3.4.1.1. China market, by By Product, 2021-2030 (USD Million) 10.3.4.1.2. China market, by By End-user, 2021-2030 (USD Million) 10.3.4.1.3. China market, by Application, 2021-2030 (USD Million) 10.3.4.2. India 10.3.4.2.1. India market, by By Product, 2021-2030 (USD Million) 10.3.4.2.2. India market, by By End-user, 2021-2030 (USD Million) 10.3.4.2.3. India market, by Application, 2021-2030 (USD Million) 10.3.4.3. Japan 10.3.4.3.1. Japan market, by By Product, 2021-2030 (USD Million) 10.3.4.3.2. Japan market, by By End-user, 2021-2030 (USD Million) 10.3.4.3.3. Japan market, by Application, 2021-2030 (USD Million) 10.3.4.4. South Korea 10.3.4.4.1. South Korea market, by By Product, 2021-2030 (USD Million) 10.3.4.4.2. South Korea market, by By End-user, 2021-2030 (USD Million) 10.3.4.4.3. South Korea market, by Application, 2021-2030 (USD Million) 10.3.4.5. Rest of ASIA PACIFIC 10.3.4.5.1. Rest of ASIA PACIFIC market, by By Product, 2021-2030 (USD Million) 10.3.4.5.2. Rest of ASIA PACIFIC market, by By End-user, 2021-2030 (USD Million) 10.3.4.5.3. Rest of ASIA PACIFIC market, by Application, 2021-2030 (USD Million) 10.4. Latin America 10.4.1. Latin America market, by By Product, 2021-2030 (USD Million) 10.4.2. Latin America market, by By End-user, 2021-2030 (USD Million) 10.4.3. Latin America market, by Application, 2021-2030 (USD Million) 10.4.4. Latin America market, by country, 2021-2030 (USD Million) 10.4.4.1. Brazil 10.4.4.1.1. Brazil market, by By Product, 2021-2030 (USD Million) 10.4.4.1.2. Brazil market, by By End-user, 2021-2030 (USD Million) 10.4.4.1.3. Brazil market, by Application, 2021-2030 (USD Million) 10.4.4.2. Mexico 10.4.4.2.1. Mexico market, by By Product, 2021-2030 (USD Million) 10.4.4.2.2. Mexico market, by By End-user, 2021-2030 (USD Million) 10.4.4.2.3. Mexico market, by Application, 2021-2030 (USD Million) 10.4.4.3. Rest of the Latin America 10.4.4.3.1. Rest of the Latin America market, by By Product, 2021-2030 (USD Million) 10.4.4.3.2. Rest of the Latin America market, by By End-user, 2021-2030 (USD Million) 10.4.4.3.3. Rest of the Latin America market, by Application, 2021-2030 (USD Million) 10.5. MEA 10.5.1. MEA market, by By Product, 2021-2030 (USD Million) 10.5.2. MEA market, by By End-user, 2021-2030 (USD Million) 10.5.3. MEA market, by Application, 2021-2030 (USD Million) 10.5.4. MEA market, by Region, 2021-2030 (USD Million) 11. Competitive Landscape 11.1 Boston Scientific Corporation 11.1.1. Company overview 11.1.2. Financial performance 11.1.3. Product Portfolio Analysis 11.1.4. Strategy & Recent Development 11.2. Medtronic PLC 11.2.1. Company overview 11.2.2. Financial performance 11.2.3. Product Portfolio Analysis 11.2.4. Strategy & Recent Development 11.3. Spectranetics Corp 11.3.1. Company overview 11.3.2. Financial performance 11.3.3. Product Portfolio Analysis 11.3.4. Strategy & Recent Development 11.4. Becton, Dickinson and Company 11.4.1. Company overview 11.4.2. Financial performance 11.4.3. Product Portfolio Analysis 11.4.4. Strategy & Recent Development 11.5. Abbott Laboratories 11.5.1. Company overview 11.5.2. Financial performance 11.5.3. Product Portfolio Analysis 11.5.4. Strategy & Recent Development 11.6. Cook Medical, Inc 11.6.1. Company overview 11.6.2. Financial performance 11.6.3. Product Portfolio Analysis 11.6.4. Strategy & Recent Development 11.7. Cardinal Health 11.7.1. Company overview 11.7.2. Financial performance 11.7.3. Product Portfolio Analysis 11.7.4. Strategy & Recent Development 11.8. ENDOCOR GmbH 11.8.1. Company overview 11.8.2. Financial performance 11.8.3. Product Portfolio Analysis 11.8.4. Strategy & Recent Development 11.9. Johnson & Johnson 11.9.1. Company overview 11.9.2. Financial performance 11.9.3. Product Portfolio Analysis 11.9.4. Strategy & Recent Development 11.10. SINOMED 11.10.1. Company overview 11.10.2. Financial performance 11.10.3. Product Portfolio Analysis 11.10.4. Strategy & Recent Development 11.11. Biotronik 11.11.1. Company overview 11.11.2. Financial performance 11.11.3. Product Portfolio Analysis 11.11.4. Strategy & Recent Development List of Tables (51 Tables) TABLE 1. MARKET, By Product, 2021-2030 (USD Million) TABLE 2. MARKET FOR Normal Balloons, BY REGION, 2021-2030 (USD Million) TABLE 3. MARKET FOR Scoring Balloons, BY REGION, 2021-2030 (USD Million) TABLE 4. MARKET FOR Drug-eluting balloons, BY REGION, 2021-2030 (USD Million) TABLE 5. MARKET FOR Cutting balloon, BY REGION, 2021-2030 (USD Million) TABLE 6. MARKET, By End-user, 2021-2030 (USD Million) TABLE 7. MARKET FOR Ambulatory Surgery Centres (ASCs), BY REGION, 2021-2030 (USD Million) TABLE 8. MARKET FOR Hospitals, BY REGION, 2021-2030 (USD Million) TABLE 9. MARKET FOR Catheterization Laboratories, BY REGION, 2021-2030 (USD Million) TABLE 10. MARKET, BY APPLICATION, 2021-2030 (USD Million) TABLE 11. MARKET FOR Coronary, BY REGION, 2021-2030 (USD Million) TABLE 12. MARKET FOR Peripheral, BY REGION, 2021-2030 (USD Million) TABLE 13. MARKET, BY REGION, 2021-2030 (USD Million) TABLE 14. NORTH AMERICA MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 15. NORTH AMERICA MARKET, By Product, 2021-2030 (USD Million) TABLE 16. NORTH AMERICA MARKET, By End-user, 2021-2030 (USD Million) TABLE 17. NORTH AMERICA MARKET, BY APPLICATION, 2021-2030 (USD Million) TABLE 18. EUROPE MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 19. EUROPE MARKET, By Product, 2021-2030 (USD Million) TABLE 20. EUROPE MARKET, By End-user, 2021-2030 (USD Million) TABLE 21. EUROPE MARKET, BY APPLICATION, 2021-2030 (USD Million) TABLE 22. ASIA-PACIFIC MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 23. ASIA-PACIFIC MARKET, By Product, 2021-2030 (USD Million) TABLE 24. ASIA-PACIFIC MARKET, By End-user, 2021-2030 (USD Million) TABLE 25. ASIA-PACIFIC MARKET, BY APPLICATION, 2021-2030 (USD Million) TABLE 26. LAMEA MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 27. LAMEA MARKET, By Product, 2021-2030 (USD Million) TABLE 28. LAMEA MARKET, By End-user, 2021-2030 (USD Million) TABLE 29. LAMEA MARKET, BY APPLICATION, 2021-2030 (USD Million) TABLE 30. Boston Scientific Corporation: COMPANY SNAPSHOT TABLE 31. Boston Scientific Corporation: OPERATING SEGMENTS TABLE 32. Medtronic PLC: COMPANY SNAPSHOT TABLE 33. Medtronic PLC: OPERATING SEGMENTS TABLE 34. Spectranetics Corp: COMPANY SNAPSHOT TABLE 35. Spectranetics Corp: OPERATING SEGMENTS TABLE 36. Becton, Dickinson and Company : COMPANY SNAPSHOT TABLE 37. Becton, Dickinson and Company: OPERATING SEGMENTS TABLE 38. Abbott Laboratories: COMPANY SNAPSHOT TABLE 39. Abbott Laboratories: OPERATING SEGMENTS TABLE 40. Cook Medical, Inc: COMPANY SNAPSHOT TABLE 41. Cook Medical, Inc: OPERATING SEGMENTS TABLE 42. Cardinal Health: COMPANY SNAPSHOT TABLE 43. Cardinal Health: OPERATING SEGMENTS TABLE 44. ENDOCOR GmbH: COMPANY SNAPSHOT TABLE 45. ENDOCOR GmbH: OPERATING SEGMENTS TABLE 46. Johnson & Johnson: COMPANY SNAPSHOT TABLE 47. Johnson & Johnson: OPERATING SEGMENTS TABLE 48. SINOMED: COMPANY SNAPSHOT TABLE 49. SINOMED: OPERATING SEGMENTS TABLE 50. Biotronik: COMPANY SNAPSHOT TABLE 51. Biotronik: OPERATING SEGMENTS List of Figures (22 Figures) Figure 1 Research Methodology Steps Figure 2 Research Design Figure 3 Breakdown of Primaries Figure 4 Research Methodology: Hypothesis Building Figure 5 Product-Based Estimation Figure 6 Top 11 Companies with Highest No. Of Patent in Last 9 Years Figure 7 No. Of Patents Granted Per Year, 2019–2020 Figure 8 Import Data for Angioplasty Balloons, By Country, 2016–2020 (USD Thousand) Figure 9 Export Data for Angioplasty Balloons, By Country, 2016–2020 (USD Thousand) Figure 10 Data Triangulation Methodology Figure 11 Market, By End-user, 2019 vs. 2025 (USD Million) Figure 12 Market Share, By Application, 2019 vs. 2025 (USD Million) Figure 13 Market Share, By Product, 2019 vs. 2025 (USD Million) Figure 14 Geographical Snapshot of the Market Figure 15 Drug-eluting balloons to Witness Higher CAGR in Market for Product Segment during Forecast Period. Figure 16 Peripheral to Witness Higher CAGR in Market for Application Segment during Forecast Period. Figure 17 Hospitals to Witness Higher CAGR in Market for End-user Segment during Forecast Period. Figure 18 Asia Pacific region Accounted for the Largest Share of the Market, By Regional Basis, in 2019 Figure 19 Drivers, Restraints, Opportunities, and Challenges Figure 20 North America: Market Snapshot Figure 21 Asia Pacific: Market Snapshot Figure 22 Vendor Dive: Evaluation Overview